The Hybrid Entrepreneur - Scanlon, Kevin
25,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in über 4 Wochen
payback
13 °P sammeln
  • Broschiertes Buch

Do you want to start your own company? This book describes the management expertise, organizational skills, and vocabulary necessary to be a successful entrepreneur based on the author's academic and business career. This book discusses: * What are the successful characteristics of an inventor, entrepreneur, and a CEO? * Understanding the vocabulary of the entrepreneur's ecosystem. * What are the evaluation criteria for the team, product, business model & exit plan? * Do consumers need or want your product? * How to create the story that will fit the right investor for funding? * Understanding…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
Do you want to start your own company? This book describes the management expertise, organizational skills, and vocabulary necessary to be a successful entrepreneur based on the author's academic and business career. This book discusses: * What are the successful characteristics of an inventor, entrepreneur, and a CEO? * Understanding the vocabulary of the entrepreneur's ecosystem. * What are the evaluation criteria for the team, product, business model & exit plan? * Do consumers need or want your product? * How to create the story that will fit the right investor for funding? * Understanding the investor evaluation and screening process. Readers will learn how to ask the right questions to build a strong ecosystem with service providers, customers, and investors. If you want to be an entrepreneur, read this book. It is about the author's personal experiences as a scientist, an inventor, an entrepreneur, CEO, and investor.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
Dr. Kevin J. Scanlon received his PhD in Molecular Biology at the University of London. Dr. Scanlon's academic achievements include co-authoring 135 scientific articles and nine medical books. He was a Leukemia Society Scholar and won the Paul Martini Medical Research Prize in Germany. He was Co-Founder & Co- Editor of the Nature Journal Cancer Gene Therapy and President of the International Society of Cell & Gene Therapy. Dr. Scanlon also holds seven issued US Patents. At Berlex-Schering AG (Berlin, Germany), he was responsible for the genomic and cancer programs in the US, Europe, and Asia. As CEO of Melanoma Diagnostic, he sold his company to Myriad Genetics. When Chairman of the Pasadena Angels, he was identified by LA Techweek as an individual impacting the Los Angeles Business Community on a significant scale. He was also executive member of the Tech Coast Angels in Los Angeles and investment advisor to Sky Ventures in Boston.